FDA NEWS

FDA requests more info on Wyeth's pneumonia drug - Forbes
Wyeth said Thursday the Food and Drug Administration will require more information on the safety and effectiveness of its antibiotic Tygacil in treating community-acquired pneumonia before granting approval. Tygacil is currently approved to treat
Source: www.forbes.com

Avastin Added to Chemo Helps Women With Advanced Breast Cancer - Atlanta Journal Constitution
SATURDAY, May 31 (HealthDay News) -- Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows. Previous studies have found that adding Avastin (bevacizumab) to the
Source: www.ajc.com

FDA panel favors Glaxo, Ligand blood drug - San Francisco Gate
Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline and Ligand Pharmaceuticals is effective for short-term use, despite reservations by FDA scientists. A panel of outside advisers voted unanimously in
Source: www.sfgate.com

Analyst: J&J blood-clot drug poised for success - CNBC
NEW YORK - The anti-bloodclotting drug Rivaroxaban could help Johnson & Johnson fight off anticipated revenue losses from generic competition, according to a Deutsche Bank-North America analyst. The drug, which treats blood clots after orthopedic
Source: www.cnbc.com

Gilead buying hypertension drug from Navitas - CNN Money
NEW YORK (Associated Press) - Biotechnology company Gilead Sciences Inc. said Thursday it will buy privately held Navitas Assets' hypertension treatment Cicletanine for an undisclosed amount, in a move to enhance its product pipeline. The drug is
Source: money.cnn.com

J&J blood clot drug beats Sanofi-Aventis' Lovenox - Boston Globe
NEW YORK— Johnson & Johnson said Friday its experimental drug to treat blood clots after orthopedic surgery proved more effective in a late-stage trial than a competing drug from Sanofi- Aventis SA which is already on the market. Rivaroxaban, 10
Source: www.boston.com

FDA panel favors Glaxo, Ligand blood drug - Los Angeles Times
WASHINGTON -- Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline PLC and Ligand Pharmaceuticals Inc. is effective for short-term use, despite reservations by FDA scientists. A panel of 16 outside
Source: www.latimes.com